{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:39:20Z","timestamp":1784000360595,"version":"3.55.0"},"reference-count":201,"publisher":"Pleiades Publishing Ltd","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1134\/s0006297923070040","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T09:02:09Z","timestamp":1689843729000},"page":"892-911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanisms of Secondary Leukemia Development Caused by Treatment with DNA Topoisomerase Inhibitors"],"prefix":"10.1134","volume":"88","author":[{"given":"Nikolai A.","family":"Lomov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir S.","family":"Viushkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Rubtsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"2506_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.blre.2010.11.001","volume":"25","author":"M. W. Becker","year":"2011","unstructured":"Becker, M. W., and Jordan, C. T. (2011) Leukemia stem cells in 2010: Current understanding and future directions, Blood Rev., 25, 75-81, \nhttps:\/\/doi.org\/10.1016\/j.blre.2010.11.001.","journal-title":"Blood Rev."},{"key":"2506_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11684-012-0215-5","volume":"6","author":"J. H. Wang","year":"2012","unstructured":"Wang, J. H. (2012) Mechanisms and impacts of chromosomal translocations in cancers, Front. Med., 6, 263-274, \nhttps:\/\/doi.org\/10.1007\/s11684-012-0215-5.","journal-title":"Front. Med."},{"key":"2506_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ng.3230","volume":"47","author":"A. K. Andersson","year":"2015","unstructured":"Andersson, A. K., Ma, J., Wang, J., Chen, X., Gedman, A. L., Dang, J., Nakitandwe, J., Holmfeldt, L., Parker, M., Easton, J., Huether, R., Kriwacki, R., Rusch, M., Wu, G., Li, Y., Mulder, H., Raimondi, S., Pounds, S., Kang, G., Shi, L., Becksfort, J., Gupta, P., Payne-Turner, D., Vadodaria, B., Boggs, K., Yergeau, D., Manne, J., Song, G., Edmonson, M., Nagahawatte, P., Wei, L., Cheng, C., Pei, D., Sutton, R., Venn, N. C., Chetcuti, A., Rush, A., Catchpoole, D., Heldrup, J., Fioretos, T., Lu, C., Ding, L., Pui, C. H., Shurtleff, S., Mullighan, C. G., Mardis, E. R., Wilson, R. K., Gruber, T. A., Zhang, J., and Downing, J.\u00a0R. (2015) The\u00a0landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias, Nat. Genet., 47, 330-337, \nhttps:\/\/doi.org\/10.1038\/ng.3230.","journal-title":"Nat. Genet."},{"key":"2506_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ccell.2015.03.016","volume":"27","author":"M. Greaves","year":"2015","unstructured":"Greaves, M. (2015) When one mutation is all it takes, Cancer Cell, 27, 433-434, \nhttps:\/\/doi.org\/10.1016\/j.ccell.2015.03.016.","journal-title":"Cancer Cell"},{"key":"2506_CR5","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","volume":"114","author":"B. V. Balgobind","year":"2009","unstructured":"Balgobind, B. V., Raimondi, S. C., Harbott, J., Zimmermann, M., Alonzo, T. A., Auvrignon, A., Beverloo, H. B., Chang, M., Creutzig, U., Dworzak, M. N., Forestier, E., Gibson, B., Hasle, H., Harrison, C. J., Heerema, N. A., Kaspers, G. J. L., Leszl, A., Litvinko, N., Lo Nigro, L., Morimoto, A., Perot, C., Pieters, R., Reinhardt, D., Rubnitz, J. E., Smith, F. O., Stary, J., Stasevich, I., Strehl, S., Taga, T., Tomizawa, D., Webb, D., Zemanova, Z., Zwaan, C. M., and Van Den Heuvel-Eibrink, M.\u00a0M. (2009) Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study, Blood, 114, 2489-2496, \nhttps:\/\/doi.org\/10.1182\/blood-2009-04-215152.","journal-title":"Blood"},{"key":"2506_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H. D\u00f6hner","year":"2017","unstructured":"D\u00f6hner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., B\u00fcchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., Levine, R. L., Lo-Coco, F., Naoe, T., Niederwieser, D., Ossenkoppele, G. J., Sanz, M., Sierra, J., Tallman, M. S., Tien, H. F., Wei, A. H., L\u00f6wenberg, B., and Bloomfield, C. D. (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel, Blood,\u00a0129, 424-447, \nhttps:\/\/doi.org\/10.1182\/blood-2016-08-733196.","journal-title":"Blood"},{"key":"2506_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/leu.2017.213","volume":"32","author":"C. Meyer","year":"2018","unstructured":"Meyer, C., Burmeister, T., Gr\u00f6ger, D., Tsaur, G., Fechina, L., Renneville, A., Sutton, R., Venn, N. C., Emerenciano, M., Pombo-De-Oliveira, M. S., Barbieri Blunck, C., Almeida Lopes, B., Zuna, J., Trka, J., Ballerini, P., Lapillonne, H., De Braekeleer, M., Cazzaniga, G., Corral Abascal, L., Van Der Velden, V. H. J., Delabesse, E., Park, T. S., Oh, S. H., Silva, M. L. M., Lund-Aho, T., Juvonen, V., Moore, A. S., Heidenreich, O., Vormoor, J., Zerkalenkova, E., Olshanskaya, Y., Bueno, C., Menendez, P., Teigler-Schlegel, A., Zur Stadt, U., Lentes, J., G\u00f6hring, G., Kustanovich, A., Aleinikova, O., Sch\u00e4fer, B. W., Kubetzko, S., Madsen, H. O., Gruhn, B., Duarte, X., Gameiro, P., Lippert, E., Bidet, A., Cayuela, J. M., Clappier, E., Alonso, C. N., Zwaan, C. M., Van Den Heuvel-Eibrink, M. M., Izraeli, S., Trakhtenbrot, L., Archer, P., Hancock, J., M\u00f6ricke, A., Alten, J., Schrappe, M., Stanulla, M., Strehl, S., Attarbaschi, A., Dworzak, M., Haas, O. A., Panzer-Gr\u00fcmayer, R., Sed\u00e9k, L., Szczepa, T., Caye, A., Suarez, L., Cav\u00e9, H., and Marschalek, R. (2018) The\u00a0MLL recombinome of acute leukemias in 2017, Leukemia, 32, 273-284, \nhttps:\/\/doi.org\/10.1038\/leu.2017.213.","journal-title":"Leukemia"},{"key":"2506_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/10408363.2020.1844135","volume":"58","author":"N. Lomov","year":"2021","unstructured":"Lomov, N., Zerkalenkova, E., Lebedeva, S., Viushkov, V., and Rubtsov, M. A. (2021) Cytogenetic and molecular genetic methods for chromosomal translocations detection with reference to the KMT2A\/MLL gene, Crit. Rev. Clin. Lab. Sci., 58, 180-206, \nhttps:\/\/doi.org\/10.1080\/10408363.2020.1844135.","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"2506_CR9","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/leu.2017.106","volume":"31","author":"D. Germini","year":"2017","unstructured":"Germini, D., Tsfasman, T., Klibi, M., El-Amine, R., Pichugin, A., Iarovaia, O. V., Bilhou-Nabera, C., Subra, F., Bou Saada, Y., Sukhanova, A., Boutboul, D., Rapha\u00ebl, M., Wiels, J., Razin, S. V., Bury-Mon\u00e9, S., Oksenhendler, E., Lipinski, M., and Vassetzky, Y. S. (2017) HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells, Leukemia, 31, 2515-2522, \nhttps:\/\/doi.org\/10.1038\/leu.2017.106.","journal-title":"Leukemia"},{"key":"2506_CR10","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","volume":"133","author":"B. M. Grande","year":"2019","unstructured":"Grande, B. M., Gerhard, D. S., Jiang, A., Griner, N. B., Abramson, J. S., Alexander, T. B., Allen, H., Ayers, L. W., Bethony, J. M., Bhatia, K., Bowen, J., Casper, C., Choi, J. K., Culibrk, L., Davidsen, T. M., Dyer, M. A., Gastier-Foster, J. M., Gesuwan, P., Greiner, T. C., Gross, T. G., Hanf, B., Harris, N. L., He, Y., Irvin, J. D., Jaffe, E. S., Jones, S. J. M., Kerchan, P., Knoetze, N., Leal, F. E., Lichtenberg, T. M., Ma, Y., Martin, J. P., Martin, M. R., Mbulaiteye, S. M., Mullighan, C. G., Mungall, A. J., Namirembe, C., Novik, K., Noy, A., Ogwang, M. D., Omoding, A., Orem, J., Reynolds, S. J., Rushton, C. K., Sandlund, J. T., Schmitz, R., Taylor, C., Wilson, W. H., Wright, G. W., Zhao, E. Y., Marra, M. A., Morin, R. D., and Staudt, L. M. (2019) Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma, Blood, 133, 1313-1324, \nhttps:\/\/doi.org\/10.1182\/blood-2018-09-871418.","journal-title":"Blood"},{"key":"2506_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc.2016.40","volume":"16","author":"M. R. Lieber","year":"2016","unstructured":"Lieber, M. R. (2016) Mechanisms of human lymphoid chromosomal translocations, Nat. Rev. Cancer, 16, 387-398, \nhttps:\/\/doi.org\/10.1038\/nrc.2016.40.","journal-title":"Nat. Rev. Cancer"},{"key":"2506_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","volume":"12","author":"W. P. Roos","year":"2006","unstructured":"Roos, W. P., and Kaina, B. (2006) DNA damage-induced cell death by apoptosis, Trends Mol. Med., 12, 440-450, \nhttps:\/\/doi.org\/10.1016\/j.molmed.2006.07.007.","journal-title":"Trends Mol. Med."},{"key":"2506_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1053\/j.seminoncol.2013.09.013","volume":"40","author":"S. Bhatia","year":"2013","unstructured":"Bhatia, S. (2013) Therapy-related myelodysplasia and acute myeloid leukemia, Semin. Oncol., 40, 666-675, \nhttps:\/\/doi.org\/10.1053\/j.seminoncol.2013.09.013.","journal-title":"Semin. Oncol."},{"key":"2506_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.leu.2403187","volume":"18","author":"C. Schoch","year":"2004","unstructured":"Schoch, C., Kern, W., Schnittger, S., Hiddemann, W., and Haferlach, T. (2004) Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de\u00a0novo AML, Leukemia, 18, 120-125, \nhttps:\/\/doi.org\/10.1038\/sj.leu.2403187.","journal-title":"Leukemia"},{"key":"2506_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11912-007-0050-z","volume":"9","author":"G. Borthakur","year":"2007","unstructured":"Borthakur, G., and Estey, E. E. (2007) Therapy-related acute myelogenous leukemia and myelodysplastic syndrome, Curr. Oncol. Rep., 9, 373-377, \nhttps:\/\/doi.org\/10.1007\/s11912-007-0050-z.","journal-title":"Curr. Oncol. Rep."},{"key":"2506_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.seminoncol.2008.04.012","volume":"35","author":"L. A. Godley","year":"2008","unstructured":"Godley, L. A., and Larson, R. A. (2008) Therapy-related myeloid leukemia, Semin. Oncol., 35, 418-429, \nhttps:\/\/doi.org\/10.1053\/j.seminoncol.2008.04.012.","journal-title":"Semin. Oncol."},{"key":"2506_CR17","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1200\/JCO.2014.60.0890","volume":"33","author":"L. S. G. \u00d8stg\u00e5rd","year":"2015","unstructured":"\u00d8stg\u00e5rd, L. S. G., Medeiros, B. C., Sengel\u00f8v, H., N\u00f8rgaard, M., Andersen, M. K., Dufva, I., Friis, L. S., Kjeldsen, E., Marcher, C. W., Preiss, B., Severinsen, M., and N\u00f8rgaard, J. M. (2015) Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: A\u00a0national population-based cohort study, J.\u00a0Clin. Oncol., 33, 3641-3649, \nhttps:\/\/doi.org\/10.1200\/JCO.2014.60.0890.","journal-title":"J.\u00a0Clin. Oncol."},{"key":"2506_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40487-020-00111-7","volume":"8","author":"T. Tiruneh","year":"2020","unstructured":"Tiruneh, T., Enawgaw, B., and Shiferaw, E. (2020) Genetic pathway in the pathogenesis of therapy-related myeloid neoplasms: a literature review, Oncol. Ther., 8, 45-57, \nhttps:\/\/doi.org\/10.1007\/s40487-020-00111-7.","journal-title":"Oncol. Ther."},{"key":"2506_CR19","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood.V99.6.1909","volume":"99","author":"J. Pedersen-Bjergaard","year":"2002","unstructured":"Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H., and Nerlov, C. (2002) Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia, Blood, 99, 1909-1912, \nhttps:\/\/doi.org\/10.1182\/blood.V99.6.1909.","journal-title":"Blood"},{"key":"2506_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1309\/AJCPD85MCOHHCOMQ","volume":"132","author":"M. Czader","year":"2009","unstructured":"Czader, M., and Orazi, A. (2009) Therapy-related myeloid neoplasms, Am.\u00a0J. Clin. Pathol., 132, 410-425, \nhttps:\/\/doi.org\/10.1309\/AJCPD85MCOHHCOMQ.","journal-title":"Am.\u00a0J. Clin. Pathol."},{"key":"2506_CR21","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","volume":"117","author":"S. Kayser","year":"2011","unstructured":"Kayser, S., D\u00f6hner, K., Krauter, J., K\u00f6hne, C.-H., Horst, H. A., Held, G., von Lilienfeld-Toal, M., Wilhelm, S., K\u00fcndgen, A., G\u00f6tze, K., Rummel, M., Nachbaur, D., Schlegelberger, B., G\u00f6hring, G., Sp\u00e4th, D., Morlok, C., Zucknick, M., Ganser, A., D\u00f6hner, H., Schlenk, R. F., and German-Austrian AMLSG (2011) The\u00a0impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML, Blood, 117, 2137-2145, \nhttps:\/\/doi.org\/10.1182\/blood-2010-08-301713.","journal-title":"Blood"},{"key":"2506_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc.2017.60","volume":"17","author":"M. E. McNerney","year":"2017","unstructured":"McNerney, M. E., Godley, L. A., and Le Beau, M. M. (2017) Therapy-related myeloid neoplasms: When genetics and environment collide, Nat. Rev. Cancer, 17, 513-527, \nhttps:\/\/doi.org\/10.1038\/nrc.2017.60.","journal-title":"Nat. Rev. Cancer"},{"key":"2506_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/oxfordjournals.annonc.a058121","volume":"3","author":"M. J. Ratain","year":"1992","unstructured":"Ratain, M. J., and Rowley, J. D. (1992) Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase\u00a0II: From the bedside to the target genes, Ann. Oncol., 3, 107-111, \nhttps:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a058121.","journal-title":"Ann. Oncol."},{"key":"2506_CR24","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/sj.leu.2402713","volume":"16","author":"N. Mauritzson","year":"2002","unstructured":"Mauritzson, N., Albin, M., Rylander, L., Billstr\u00f6m, R., Ahlgren, T., Mikoczy, Z., Bj\u00f6rk, J., Str\u00f6mberg, U., Nilsson, P., Mitelman, F., Hagmar, L., and Johansson, B. (2002) Pooled analysis of clinical and cytogenetic features in treatment-related and de\u00a0novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761\u00a0patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001, Leukemia, 16, 2366-2378, \nhttps:\/\/doi.org\/10.1038\/sj.leu.2402713.","journal-title":"Leukemia"},{"key":"2506_CR25","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","volume":"34","author":"K. R. Hande","year":"1998","unstructured":"Hande, K. R. (1998) Etoposide: four decades of development of a topoisomerase\u00a0ii inhibitor, Eur.\u00a0J. Cancer, 34, 1514-1521, \nhttps:\/\/doi.org\/10.1016\/S0959-8049(98)00228-7.","journal-title":"Eur.\u00a0J. Cancer"},{"key":"2506_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1126\/science.104.2698.244","volume":"104","author":"L. S. King","year":"1946","unstructured":"King, L. S., and Sullivan, M. (1946) The\u00a0similarity of the effect of podophyllin and colchicine and their use in the treatment of condylomata acuminata, Science, 104, 244-245, \nhttps:\/\/doi.org\/10.1126\/science.104.2698.244.","journal-title":"Science"},{"key":"2506_CR27","first-page":"1295","volume":"10","author":"E. M. Greenspan","year":"1950","unstructured":"Greenspan, E. M. (1950) Effect of alpha-peltatin, beta-peltatin, and podophyllotoxin on lymphomas and other transplanted tumors, J.\u00a0Natl. Cancer Inst., 10, 1295-1333.","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"2506_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2174\/1568011054222364","volume":"5","author":"E. L. Baldwin","year":"2005","unstructured":"Baldwin, E. L., and Osheroff, N. (2005) Etoposide, topoisomerase\u00a0II and cancer, Curr. Med. Chem. Anticancer Agents, 5, 363-372, \nhttps:\/\/doi.org\/10.2174\/1568011054222364.","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"2506_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0167-4781(98)00132-8","volume":"1400","author":"D. A. Burden","year":"1998","unstructured":"Burden, D. A., and Osheroff, N. (1998) Mechanism of action of eukaryotic topoisomerase\u00a0II and drugs targeted to the enzyme, Biochim. Biophys. Acta, 1400, 139-154, \nhttps:\/\/doi.org\/10.1016\/S0167-4781(98)00132-8.","journal-title":"Biochim. Biophys. Acta"},{"key":"2506_CR30","first-page":"120","volume":"43","author":"A. J. Wozniak","year":"1983","unstructured":"Wozniak, A. J., and Ross, W. E. (1983) DNA damage as a basis for 4\u2032-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity, Cancer Res., 43, 120-124.","journal-title":"Cancer Res."},{"key":"2506_CR31","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/171964b0","volume":"171","author":"J. D. Watson","year":"1953","unstructured":"Watson, J. D., and Crick, F. H. C. (1953) Genetical implications of the structure of deoxyribonucleic acid, Nature, 171, 964-967, \nhttps:\/\/doi.org\/10.1038\/171964b0.","journal-title":"Nature"},{"key":"2506_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1073\/pnas.40.9.783","volume":"40","author":"M. Delbr\u00fcck","year":"1954","unstructured":"Delbr\u00fcck, M. (1954) On the replication of desoxyribonucleic acid (DNA), Proc. Natl. Acad. Sci. USA, 40, 783-788, \nhttps:\/\/doi.org\/10.1073\/pnas.40.9.783.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202000286","volume":"43","author":"S. J. McKie","year":"2021","unstructured":"McKie, S. J., Neuman, K. C., and Maxwell, A. (2021) DNA topoisomerases: Advances in understanding of cellular roles and multi-protein complexes via structure-function analysis, BioEssays, 43, e2000286, \nhttps:\/\/doi.org\/10.1002\/bies.202000286.","journal-title":"BioEssays"},{"key":"2506_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","volume":"70","author":"J. J. Champoux","year":"2001","unstructured":"Champoux, J. J. (2001) DNA topoisomerases: structure, function, and mechanism, Annu. Rev. Biochem., 70, 369-413, \nhttps:\/\/doi.org\/10.1146\/annurev.biochem.70.1.369.","journal-title":"Annu. Rev. Biochem."},{"key":"2506_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0022-2836(87)90369-X","volume":"194","author":"J. B. Bliska","year":"1987","unstructured":"Bliska, J. B., and Cozzarelli, N. R. (1987) Use of site-specific recombination as a probe of DNA structure and metabolism in\u00a0vivo, J.\u00a0Mol. Biol., 194, 205-218, \nhttps:\/\/doi.org\/10.1016\/0022-2836(87)90369-X.","journal-title":"J.\u00a0Mol. Biol."},{"key":"2506_CR36","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1101\/gad.9.22.2859","volume":"9","author":"E. L. Zechiedrich","year":"1995","unstructured":"Zechiedrich, E. L., and Cozzarelli, N. R. (1995) Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli, Genes Dev., 9, 2859-2869, \nhttps:\/\/doi.org\/10.1101\/gad.9.22.2859.","journal-title":"Genes Dev."},{"key":"2506_CR37","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1073\/pnas.84.4.950","volume":"84","author":"L. Yang","year":"1987","unstructured":"Yang, L., Wold, M. S., Li, J. J., Kelly, T. J., and Liu, L. F. (1987) Roles of DNA topoisomerases in simian virus 40 DNA replication in\u00a0vitro, Proc. Natl. Acad. Sci. USA, 84, 950-954, \nhttps:\/\/doi.org\/10.1073\/pnas.84.4.950.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR38","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1242\/jcs.104.4.1175","volume":"104 (Pt 4)","author":"P. Buchenau","year":"1993","unstructured":"Buchenau, P., Saumweber, H., and Arndt-Jovin, D. J. (1993) Consequences of topoisomerase\u00a0II inhibition in early embryogenesis of Drosophila revealed by in\u00a0vivo confocal laser scanning microscopy, J.\u00a0Cell Sci., 104 (Pt 4), 1175-1185, \nhttps:\/\/doi.org\/10.1242\/jcs.104.4.1175.","journal-title":"J.\u00a0Cell Sci."},{"key":"2506_CR39","doi-asserted-by":"publisher","first-page":"15365","DOI":"10.1016\/S0021-9258(17)43815-4","volume":"258","author":"L. F. Liu","year":"1983","unstructured":"Liu, L. F., Rowe, T. C., Yang, L., Tewey, K. M., and Chen, G. L. (1983) Cleavage of DNA by mammalian DNA topoisomerase\u00a0II, J.\u00a0Biol. Chem., 258, 15365-15370, \nhttps:\/\/doi.org\/10.1016\/S0021-9258(17)43815-4.","journal-title":"J.\u00a0Biol. Chem."},{"key":"2506_CR40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nsmb.2388","volume":"19","author":"B. H. Schmidt","year":"2012","unstructured":"Schmidt, B. H., Osheroff, N., and Berger, J. M. (2012) Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity, Nat. Struct. Mol. Biol., 19, 1147-1154, \nhttps:\/\/doi.org\/10.1038\/nsmb.2388.","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2506_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrc2608","volume":"9","author":"J. L. Nitiss","year":"2009","unstructured":"Nitiss, J. L. (2009) DNA topoisomerase\u00a0II and its growing repertoire of biological functions, Nat. Rev. Cancer, 9, 327-337, \nhttps:\/\/doi.org\/10.1038\/nrc2608.","journal-title":"Nat. Rev. Cancer"},{"key":"2506_CR42","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1093\/nar\/gkr258","volume":"39","author":"A. D. Bates","year":"2011","unstructured":"Bates, A. D., Berger, J. M., and Maxwell, A. (2011) The\u00a0ancestral role of ATP hydrolysis in type\u00a0II topoisomerases: prevention of DNA double-strand breaks, Nucleic Acids Res., 39, 6327-6339, \nhttps:\/\/doi.org\/10.1093\/nar\/gkr258.","journal-title":"Nucleic Acids Res."},{"key":"2506_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/ecosalplus.ESP-0010-2014","volume":"6","author":"N. G. Bush","year":"2015","unstructured":"Bush, N. G., Evans-roberts, K., and Maxwell, A. (2015) Macromolecules DNA topoisomerases, EcoSal Plus, 6, 1-34, \nhttps:\/\/doi.org\/10.1128\/ecosalplus.ESP-0010-2014.","journal-title":"EcoSal Plus"},{"key":"2506_CR44","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/j.jmb.2019.07.008","volume":"431","author":"B. D. Bax","year":"2019","unstructured":"Bax, B. D., Murshudov, G., Maxwell, A., and Germe, T. (2019) DNA topoisomerase inhibitors: trapping a DNA-cleaving machine in motion, J.\u00a0Mol. Biol., 431, 3427-3449, \nhttps:\/\/doi.org\/10.1016\/j.jmb.2019.07.008.","journal-title":"J.\u00a0Mol. Biol."},{"key":"2506_CR45","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1021\/acs.biochem.1c00240","volume":"60","author":"K. R. Vann","year":"2021","unstructured":"Vann, K. R., Oviatt, A. A., and Osheroff, N. (2021) Topoisomerase\u00a0II poisons: converting essential enzymes into molecular scissors, Biochemistry, 60, 1630-1641, \nhttps:\/\/doi.org\/10.1021\/acs.biochem.1c00240.","journal-title":"Biochemistry"},{"key":"2506_CR46","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1021\/bi00221a012","volume":"30","author":"M. J. Robinson","year":"1991","unstructured":"Robinson, M. J., and Osheroff, N. (1991) Effects of antineoplastic drugs on the post-strand-passage DNA cleavage\/religation equilibrium of topoisomerase\u00a0II, Biochemistry, 30, 1807-1813, \nhttps:\/\/doi.org\/10.1021\/bi00221a012.","journal-title":"Biochemistry"},{"key":"2506_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/genes7070032","volume":"7","author":"H. Yan","year":"2016","unstructured":"Yan, H., Tammaro, M., and Liao, S. (2016) Collision of trapped topoisomerase 2 with transcription and replication: generation and repair of DNA double-strand breaks with 5\u2032 adducts, Genes (Basel), 7, 32, \nhttps:\/\/doi.org\/10.3390\/genes7070032.","journal-title":"Genes (Basel)"},{"key":"2506_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00018-019-03367-z","volume":"77","author":"A. A. Riccio","year":"2020","unstructured":"Riccio, A. A., Schellenberg, M. J., and Williams, R. S. (2020) Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution, Cell. Mol. Life Sci., 77, 81-91, \nhttps:\/\/doi.org\/10.1007\/s00018-019-03367-z.","journal-title":"Cell. Mol. Life Sci."},{"key":"2506_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1124\/molpharm.121.000374","volume":"101","author":"R. L. Swan","year":"2022","unstructured":"Swan, R. L., Cowell, I. G., and Austin, C. A. (2022) Mechanisms to repair stalled topoisomerase II-DNA covalent complexes, Mol. Pharmacol., 101, 24-32, \nhttps:\/\/doi.org\/10.1124\/molpharm.121.000374.","journal-title":"Mol. Pharmacol."},{"key":"2506_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbcan.2012.09.002","volume":"1835","author":"M. T. Tomicic","year":"2013","unstructured":"Tomicic, M. T., and Kaina, B. (2013) Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors, Biochim. Biophys. Acta Rev. Cancer, 1835, 11-27, \nhttps:\/\/doi.org\/10.1016\/j.bbcan.2012.09.002.","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"2506_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2006.11.005","volume":"252","author":"A. Montecucco","year":"2007","unstructured":"Montecucco, A., and Biamonti, G. (2007) Cellular response to etoposide treatment, Cancer Lett., 252, 9-18, \nhttps:\/\/doi.org\/10.1016\/j.canlet.2006.11.005.","journal-title":"Cancer Lett."},{"key":"2506_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2006.12.006","volume":"391","author":"O. L. Kantidze","year":"2007","unstructured":"Kantidze, O. L., and Razin, S. V. (2007) Chemotherapy-related secondary leukemias: a role for DNA repair by error-prone non-homologous end joining in topoisomerase\u00a0II\u00a0\u2013 induced chromosomal rearrangements, Gene, 391, 76-79, \nhttps:\/\/doi.org\/10.1016\/j.gene.2006.12.006.","journal-title":"Gene"},{"key":"2506_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/gcc.22124","volume":"53","author":"K. A. Smith","year":"2014","unstructured":"Smith, K. A., Cowell, I. G., Zhang, Y., Sondka, Z., and Austin, C. A. (2014) The\u00a0role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1, Genes Chromosomes Cancer, 53, 117-128, \nhttps:\/\/doi.org\/10.1002\/gcc.22124.","journal-title":"Genes Chromosomes Cancer"},{"key":"2506_CR54","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.042702899","volume":"99","author":"Y. Zhang","year":"2002","unstructured":"Zhang, Y., Strissel, P., Strick, R., Chen, J., Nucifora, G., Le Beau, M. M., Larson, R. A., and Rowley, J. D. (2002) Genomic DNA breakpoints in AML1\/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia, Proc. Natl. Acad. Sci. USA, 99, 3070-3075, \nhttps:\/\/doi.org\/10.1073\/pnas.042702899.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR55","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/hmg\/9.11.1671","volume":"9","author":"P. L. Strissel","year":"2000","unstructured":"Strissel, P. L., Strick, R., Tomek, R. J., Roe, B. A., Rowley, J.\u00a0D., and Zeleznik-Le, N.\u00a0J. (2000) DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL\/AF9 translocations and leukemogenesis, Hum. Mol. Genet., 9, 1671-1679, \nhttps:\/\/doi.org\/10.1093\/hmg\/9.11.1671.","journal-title":"Hum. Mol. Genet."},{"key":"2506_CR56","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1073\/pnas.1204406109","volume":"109","author":"I. G. Cowell","year":"2012","unstructured":"Cowell, I. G., Sondka, Z., Smith, K., Lee, K. C., Manville, C. M., Sidorczuk-Lesthuruge, M., Rance, H. A., Padget, K., Jackson, G. H., Adachi, N., and Austin, C.\u00a0A. (2012) Model for MLL translocations in therapy-related leukemia involving topoisomerase II\u03b2-mediated DNA strand breaks and gene proximity, Proc. Natl. Acad. Sci. USA, 109, 8989-8994, \nhttps:\/\/doi.org\/10.1073\/pnas.1204406109.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179824","volume":"23","author":"N. A. Lomov","year":"2022","unstructured":"Lomov, N. A., Viushkov, V. S., Ulianov, S. V., Gavrilov, A. A., Alexeyevsky, D.\u00a0A., Artemov, A. V., Razin, S.\u00a0V., and Rubtsov, M.\u00a0A. (2022) Recurrent translocations in topoisomerase inhibitor-related leukemia are determined by the features of DNA breaks rather than by the proximity of the translocating genes, Int.\u00a0J. Mol. Sci., 23, 9824, \nhttps:\/\/doi.org\/10.3390\/ijms23179824.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2506_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/gcc.10040","volume":"33","author":"J. D. Rowley","year":"2002","unstructured":"Rowley, J. D., and Olney, H. J. (2002) International Workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report, Genes Chromosomes Cancer, 33, 331-345, \nhttps:\/\/doi.org\/10.1002\/gcc.10040.","journal-title":"Genes Chromosomes Cancer"},{"key":"2506_CR59","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.leu.2405078","volume":"22","author":"J. Pedersen-Bjergaard","year":"2008","unstructured":"Pedersen-Bjergaard, J., Andersen, M. K., Andersen, M.\u00a0T., and Christiansen, D.\u00a0H. (2008) Genetics of therapy-related myelodysplasia and acute myeloid leukemia, Leukemia, 22, 240-248, \nhttps:\/\/doi.org\/10.1038\/sj.leu.2405078.","journal-title":"Leukemia"},{"key":"2506_CR60","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12185-018-2439-x","volume":"108","author":"T. Imamura","year":"2018","unstructured":"Imamura, T., Taga, T., Takagi, M., Kawasaki, H., Koh, K., Taki, T., Adachi, S., Manabe, A., and Ishida, Y. (2018) Nationwide survey of therapy-related leukemia in childhood in Japan, Int.\u00a0J. Hematol., 108, 91-97, \nhttps:\/\/doi.org\/10.1007\/s12185-018-2439-x.","journal-title":"Int.\u00a0J. Hematol."},{"key":"2506_CR61","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1309\/AJCP5ETHDXO6NCGZ","volume":"131","author":"S. A. Gustafson","year":"2009","unstructured":"Gustafson, S. A., Lin, P., Chen, S. S., Chen, L., Abruzzo, L.\u00a0V., Luthra, R., Medeiros, L.\u00a0J., and Wang, S.\u00a0A. (2009) Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de\u00a0novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome, Am.\u00a0J. Clin. Pathol., 131, 647-655, \nhttps:\/\/doi.org\/10.1309\/AJCP5ETHDXO6NCGZ.","journal-title":"Am.\u00a0J. Clin. Pathol."},{"key":"2506_CR62","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gcc.10042","volume":"33","author":"M. L. Slovak","year":"2002","unstructured":"Slovak, M. L., Bedell, V., Popplewell, L., Arber, D.\u00a0A., Schoch, C., and Slater, R. (2002) 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop, Genes Chromosomes Cancer, 33, 379-394, \nhttps:\/\/doi.org\/10.1002\/gcc.10042.","journal-title":"Genes Chromosomes Cancer"},{"key":"2506_CR63","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","volume":"129","author":"R. Sood","year":"2017","unstructured":"Sood, R., Kamikubo, Y., and Liu, P. (2017) Role of RUNX1 in hematological malignancies, Blood, 129, 2070-2082, \nhttps:\/\/doi.org\/10.1182\/blood-2016-10-687830.","journal-title":"Blood"},{"key":"2506_CR64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/ol.2017.6151","volume":"14","author":"K. Tanaka","year":"2017","unstructured":"Tanaka, K., Oshikawa, G., Akiyama, H., Ishida, S., Nagao, T., Yamamoto, M., and Miura, O. (2017) Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1\/MDS1\/EVI1 fusion proteins: A\u00a0case report, Oncol. Lett., 14, 97-102, \nhttps:\/\/doi.org\/10.3892\/ol.2017.6151.","journal-title":"Oncol. Lett."},{"key":"2506_CR65","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/gcc.10055","volume":"34","author":"Y. Sato","year":"2002","unstructured":"Sato, Y., Izumi, T., Kanamori, H., Davis, E. M., Miura, Y., Larson, R. A., Le Beau, M.\u00a0M., Ozawa, K., and Rowley, J.\u00a0D. (2002) t(1;3)(p36;p21) is a recurring therapy-related translocation, Genes Chromosomes Cancer, 34, 186-192, \nhttps:\/\/doi.org\/10.1002\/gcc.10055.","journal-title":"Genes Chromosomes Cancer"},{"key":"2506_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2141.2011.08918.x","volume":"156","author":"F. P. Duhoux","year":"2012","unstructured":"Duhoux, F. P., Ameye, G., Montano-Almendras, C. P., Bahloula, K., Mozziconacci, M. J., Laibe, S., Wlodarska, I., Michaux, L., Talmant, P., Richebourg, S., Lippert, E., Speleman, F., Herens, C., Struski, S., Raynaud, S., Auger, N., Nadal, N., Rack, K., Mugneret, F., Tigaud, I., Lafage, M., Taviaux, S., Roche-Lestienne, C., Latinne, D., Libouton, J.\u00a0M., Demoulin, J.\u00a0B., and Poirel,\u00a0H.\u00a0A. (2012) PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies, Br.\u00a0J. Haematol., 156, 76-88, \nhttps:\/\/doi.org\/10.1111\/j.1365-2141.2011.08918.x.","journal-title":"Br.\u00a0J. Haematol."},{"key":"2506_CR67","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1046\/j.1365-2141.2001.03000.x","volume":"114","author":"M. K. Andersen","year":"2001","unstructured":"Andersen, M. K., Christiansen, D. H., Jensen, B. A., Ernst, P., Hauge, G., and Pedersen-Bjergaard, J. (2001) Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase\u00a0II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992, Br.\u00a0J. Haematol., 114, 539-543, \nhttps:\/\/doi.org\/10.1046\/j.1365-2141.2001.03000.x.","journal-title":"Br.\u00a0J. Haematol."},{"key":"2506_CR68","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.3390\/ijerph9062075","volume":"9","author":"I. G. Cowell","year":"2012","unstructured":"Cowell, I. G., and Austin, C. A. (2012) Mechanism of generation of therapy related leukemia in response to anti-topoisomerase\u00a0II agents, J.\u00a0Environ. Res. Public Health, 9, 2075-2091, \nhttps:\/\/doi.org\/10.3390\/ijerph9062075.","journal-title":"J.\u00a0Environ. Res. Public Health"},{"key":"2506_CR69","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.leu.2401016","volume":"12","author":"A.\u00a0V. Moorman","year":"1998","unstructured":"Moorman, A.\u00a0V., Hagemeijer, A., Charrin, C., Rieder, H., and Secker-Walker, L.\u00a0M. (1998) Clinical profile of 53\u00a0patients, Leukemia, 12, 805-810, \nhttps:\/\/doi.org\/10.1038\/sj.leu.2401016.","journal-title":"Leukemia"},{"key":"2506_CR70","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.leu.2404542","volume":"21","author":"C. Meyer","year":"2007","unstructured":"Meyer, C., Burmeister, T., Strehl, S., Schneider, B., Hubert, D., Zach, O., Haas, O., Klingebiel, T., Dingermann, T., and Marschalek, R. (2007) Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia, Leukemia, 21, 588-590, \nhttps:\/\/doi.org\/10.1038\/sj.leu.2404542.","journal-title":"Leukemia"},{"key":"2506_CR71","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1093\/emboj\/19.17.4655","volume":"19","author":"C. Lavau","year":"2000","unstructured":"Lavau, C., Du, C., Thirman, M., and Zeleznik-Le, N. (2000) Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia, EMBO\u00a0J., 19, 4655-4664, \nhttps:\/\/doi.org\/10.1093\/emboj\/19.17.4655.","journal-title":"EMBO\u00a0J."},{"key":"2506_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3343\/kjlm.2011.31.1.13","volume":"31","author":"B. J. Yoo","year":"2011","unstructured":"Yoo, B. J., Nam, M. H., Sung, H. J., Lim, C. S., Lee, C.\u00a0K., Cho, Y.\u00a0J., Lee, K.\u00a0N., and Yoon, S.\u00a0Y. (2011) A\u00a0case of therapy-related acute lymphoblastic leukemia with t(11;19) (q23;p13.3) and MLL\/MLLT1 gene rearrangement, Korean J.\u00a0Lab. Med., 31, 13-17, \nhttps:\/\/doi.org\/10.3343\/kjlm.2011.31.1.13.","journal-title":"Korean J.\u00a0Lab. Med."},{"key":"2506_CR73","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00277-020-03909-7","volume":"99","author":"W. Xie","year":"2020","unstructured":"Xie, W., Tang, G., Wang, E., Kim, Y., Cloe, A., Shen, Q., Zhou, Y., Garcia-Manero, G., Loghavi, S., Hu, A. Y., Wang, S., Bueso-Ramos, C. E., Kantarjian, H.\u00a0M., Medeiros, L.\u00a0J., and Hu, S. (2020) t(11;16)(q23;p13)\/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm? Ann. Hematol., 99, 487-500, \nhttps:\/\/doi.org\/10.1007\/s00277-020-03909-7.","journal-title":"Ann. Hematol."},{"key":"2506_CR74","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ncb1591","volume":"9","author":"E. Soutoglou","year":"2007","unstructured":"Soutoglou, E., Dorn, J. F., Sengupta, K., Jasin, M., Nussenzweig, A., Ried, T., Danuser, G., and Misteli, T. (2007) Positional stability of single double-strand breaks in mammalian cells, Nat. Cell Biol., 9, 675-682, \nhttps:\/\/doi.org\/10.1038\/ncb1591.","journal-title":"Nat. Cell Biol."},{"key":"2506_CR75","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.cell.2012.02.002","volume":"148","author":"Y. Zhang","year":"2012","unstructured":"Zhang, Y., McCord, R. P., Ho, Y.-J., Lajoie, B. R., Hildebrand, D.\u00a0G., Simon, A.\u00a0C., Becker, M.\u00a0S., Alt, F.\u00a0W., and Dekker, J. (2012) Chromosomal translocations are guided by the spatial organization of the genome, Cell, 148, 908-921, \nhttps:\/\/doi.org\/10.1016\/j.cell.2012.02.002.","journal-title":"Cell"},{"key":"2506_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044196","volume":"7","author":"J. M. Engreitz","year":"2012","unstructured":"Engreitz, J. M., Agarwala, V., and Mirny, L.\u00a0A. (2012) Three-dimensional genome architecture influences partner selection for chromosomal translocations in human disease, PLoS One, 7, e44196, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0044196.","journal-title":"PLoS One"},{"key":"2506_CR77","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ijc.30461","volume":"140","author":"C. Sathitruangsak","year":"2017","unstructured":"Sathitruangsak, C., Righolt, C. H., Klewes, L., Tung Chang, D., Kotb, R., and Mai,\u00a0S. (2017) Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma, Int.\u00a0J. Cancer, 140, 400-410, \nhttps:\/\/doi.org\/10.1002\/ijc.30461.","journal-title":"Int.\u00a0J. Cancer"},{"key":"2506_CR78","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.bbamcr.2007.07.002","volume":"1773","author":"M. Falk","year":"2007","unstructured":"Falk, M., Lukasova, E., Gabrielova, B., Ondrej, V., and Kozubek, S. (2007) Chromatin dynamics during DSB repair, Biochim. Biophys. Acta, 1773, 1534-1545, \nhttps:\/\/doi.org\/10.1016\/j.bbamcr.2007.07.002.","journal-title":"Biochim. Biophys. Acta"},{"key":"2506_CR79","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nsmb.3387","volume":"24","author":"F. Aymard","year":"2017","unstructured":"Aymard, F., Aguirrebengoa, M., Guillou, E., Javierre, B. M., Bugler, B., Arnould,\u00a0C., Rocher, V., Iacovoni, J. S., Biernacka, A., Skrzypczak, M., Ginalski, K., Rowicka, M., Fraser, P., and Legube, G. (2017) Genome-wide mapping of long-range contacts unveils clustering of DNA double-strand breaks at damaged active genes, Nat. Struct. Mol. Biol., 24, 353-361, \nhttps:\/\/doi.org\/10.1038\/nsmb.3387.","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2506_CR80","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.aax7852","volume":"365","author":"H. Wang","year":"2019","unstructured":"Wang, H., Nakamura, M., Abbott, T. R., Zhao, D., Luo, K., Yu, C., Nguyen, C.\u00a0M., Lo, A., Daley, T.\u00a0P., La Russa, M., Liu, Y., and Qi, L.\u00a0S. (2019) CRISPR-mediated live imaging of genome editing and transcription, Science, 365, 1301-1305, \nhttps:\/\/doi.org\/10.1126\/science.aax7852.","journal-title":"Science"},{"key":"2506_CR81","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1038\/s41388-021-01856-9","volume":"40","author":"D. A. Ramsden","year":"2021","unstructured":"Ramsden, D. A., and Nussenzweig, A. (2021) Mechanisms driving chromosomal translocations: lost in time and space, Oncogene, 40, 4263-4270, \nhttps:\/\/doi.org\/10.1038\/s41388-021-01856-9.","journal-title":"Oncogene"},{"key":"2506_CR82","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1126\/science.1237150","volume":"341","author":"V. Roukos","year":"2013","unstructured":"Roukos, V., Voss, T. C., Schmidt, C. K., Lee, S., Wangsa, D., and Misteli, T. (2013) Spatial dynamics of chromosome translocations in living cells, Science, 341, 660-664, \nhttps:\/\/doi.org\/10.1126\/science.1237150.","journal-title":"Science"},{"key":"2506_CR83","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/bies.200800165","volume":"31","author":"O. L. Kantidze","year":"2009","unstructured":"Kantidze, O. L., and Razin, S. V. (2009) Chromatin loops, illegitimate recombination, and genome evolution, BioEssays, 31, 278-286, \nhttps:\/\/doi.org\/10.1002\/bies.200800165.","journal-title":"BioEssays"},{"key":"2506_CR84","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molcel.2019.04.030","volume":"75","author":"A. Canela","year":"2019","unstructured":"Canela, A., Maman, Y., Huang, S. N., Wutz, G., Tang, W., Zagnoli-Vieira, G., Callen, E., Wong, N., Day, A., Peters, J. M., Caldecott, K. W., Pommier, Y., and Nussenzweig, A. (2019) Topoisomerase II-induced chromosome breakage and translocation is determined by chromosome architecture and transcriptional activity, Mol. Cell, 75, 252-266.e8, \nhttps:\/\/doi.org\/10.1016\/j.molcel.2019.04.030.","journal-title":"Mol. Cell"},{"key":"2506_CR85","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.molcel.2016.02.010","volume":"61","author":"T. G. W. Graham","year":"2016","unstructured":"Graham, T. G. W., Walter, J. C., and Loparo, J. J. (2016) Two-stage synapsis of DNA ends during non-homologous end joining, Mol. Cell, 61, 850-858, \nhttps:\/\/doi.org\/10.1016\/j.molcel.2016.02.010.","journal-title":"Mol. Cell"},{"key":"2506_CR86","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1016\/j.molcel.2021.07.005","volume":"81","author":"A. K. Chaplin","year":"2021","unstructured":"Chaplin, A. K., Hardwick, S. W., Stavridi, A. K., Buehl, C. J., Goff, N. J., Ropars, V., Liang, S., De Oliveira, T. M., Chirgadze, D. Y., Meek, K., Charbonnier, J. B., and Blundell, T. L. (2021) Cryo-EM of NHEJ supercomplexes provides insights into DNA repair, Mol. Cell, 81, 3400-3409.e3, \nhttps:\/\/doi.org\/10.1016\/j.molcel.2021.07.005.","journal-title":"Mol. Cell"},{"key":"2506_CR87","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1093\/emboj\/cdf299","volume":"21","author":"L. G. DeFazio","year":"2002","unstructured":"DeFazio, L. G., Stansel, R. M., Griffith, J. D., and Chu, G. (2002) Synapsis of DNA ends by DNA-dependent protein kinase, EMBO\u00a0J., 21, 3192-3200, \nhttps:\/\/doi.org\/10.1093\/emboj\/cdf299.","journal-title":"EMBO\u00a0J."},{"key":"2506_CR88","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12370","volume":"43","author":"A. Shmakova","year":"2023","unstructured":"Shmakova, A., Lomov, N., Viushkov, V., Tsfasman, T., Kozhevnikova, Y., Sokolova, D., Pokrovsky, V., Syrkina, M., Germini, D., Rubtsov, M., and Vassetzky, Y. (2023) Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations, Cancer Commun., 43, 154-158, \nhttps:\/\/doi.org\/10.1002\/cac2.12370.","journal-title":"Cancer Commun."},{"key":"2506_CR89","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1242\/jcs.089847","volume":"125","author":"P. M. Krawczyk","year":"2012","unstructured":"Krawczyk, P. M., Borovski, T., Stap, J., Cijsouw, T., ten Cate, R., Medema, J.\u00a0P., Kanaar, R., Franken, N. A. P., and Aten, J.\u00a0A. (2012) Chromatin mobility is increased at sites of DNA double-strand breaks, J.\u00a0Cell Sci., 125, 2127-2133, \nhttps:\/\/doi.org\/10.1242\/jcs.089847.","journal-title":"J.\u00a0Cell Sci."},{"key":"2506_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075871","volume":"8","author":"S. I. Glukhov","year":"2013","unstructured":"Glukhov, S. I., Rubtsov, M. A., Alexeyevsky, D. A., Alexeevski, A. V., Razin, S. V., and Iarovaia, O. V. (2013) The\u00a0broken MLL gene is frequently located outside the inherent chromosome territory in human lymphoid cells treated with DNA topoisomerase\u00a0II poison etoposide, PLoS One, 8, e75871, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0075871.","journal-title":"PLoS One"},{"key":"2506_CR91","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"P. C. Nowell","year":"1976","unstructured":"Nowell, P. C. (1976) The\u00a0clonal evolution of tumor cell populations, Science, 194, 23-28, \nhttps:\/\/doi.org\/10.1126\/science.959840.","journal-title":"Science"},{"key":"2506_CR92","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.1073\/pnas.88.23.10431","volume":"8","author":"H. Miyoshi","year":"1991","unstructured":"Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. (1991) (8;21) breakpoints on chromosome\u00a021 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1, Proc. Natl. Acad. Sci. USA, 8, 10431-10434, \nhttps:\/\/doi.org\/10.1073\/pnas.88.23.10431.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR93","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1182\/blood.V92.8.2879","volume":"92","author":"D. Roulston","year":"1998","unstructured":"Roulston, D., Espinosa, R., Nucifora, G., Larson, R.\u00a0A., Le Beau, M.\u00a0M., and Rowley, J.\u00a0D. (1998) CBFA2(AML1) Translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy, Blood, 92, 2879-2885, \nhttps:\/\/doi.org\/10.1182\/blood.V92.8.2879.","journal-title":"Blood"},{"key":"2506_CR94","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1182\/blood.V83.10.2780.2780","volume":"83","author":"J. Pedersen-Bjergaard","year":"1994","unstructured":"Pedersen-Bjergaard, J., and Rowley, J. D. (1994) The\u00a0balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation, Blood, 83, 2780-2786, \nhttps:\/\/doi.org\/10.1182\/blood.V83.10.2780.2780.","journal-title":"Blood"},{"key":"2506_CR95","first-page":"1031","volume":"29","author":"E. De Braekeleer","year":"2009","unstructured":"De Braekeleer, E., Ferec, C., and De Braekeleer, M. (2009) RUNX1 translocations in malignant hemopathies, Anticancer Res., 29, 1031-1038.","journal-title":"Anticancer Res."},{"key":"2506_CR96","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-10-3233-2_2","volume":"962","author":"T. H. Tahirov","year":"2017","unstructured":"Tahirov, T. H., and Bushweller, J. (2017) Structure and biophysics of CBF\u03b2\/RUNX and its translocation products, Adv. Exp. Med. Biol., 962, 21-31, \nhttps:\/\/doi.org\/10.1007\/978-981-10-3233-2_2.","journal-title":"Adv. Exp. Med. Biol."},{"key":"2506_CR97","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2741\/3977","volume":"17","author":"K. Lam","year":"2012","unstructured":"Lam, K., and Zhang, D.-E. (2012) RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis, Front. Biosci. Landmark Ed., 17, 1120-1139, \nhttps:\/\/doi.org\/10.2741\/3977.","journal-title":"Front. Biosci. Landmark Ed."},{"key":"2506_CR98","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s12185-013-1347-3","volume":"97","author":"M. Ichikawa","year":"2013","unstructured":"Ichikawa, M., Yoshimi, A., Nakagawa, M., Nishimoto, N., Watanabe-Okochi, N., and Kurokawa, M. (2013) A\u00a0role for RUNX1 in hematopoiesis and myeloid leukemia, Int.\u00a0J. Hematol., 97, 726-734, \nhttps:\/\/doi.org\/10.1007\/s12185-013-1347-3.","journal-title":"Int.\u00a0J. Hematol."},{"key":"2506_CR99","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nature07619","volume":"457","author":"M. J. Chen","year":"2009","unstructured":"Chen, M. J., Yokomizo, T., Zeigler, B. M., Dzierzak, E., and Speck, N.\u00a0A. (2009) Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter, Nature, 457, 887-891, \nhttps:\/\/doi.org\/10.1038\/nature07619.","journal-title":"Nature"},{"key":"2506_CR100","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1042\/BST20180320","volume":"47","author":"K. Ottersbach","year":"2019","unstructured":"Ottersbach, K. (2019) Endothelial-to-haematopoietic transition: An\u00a0update on the process of making blood, Biochem. Soc. Trans., 47, 591-601, \nhttps:\/\/doi.org\/10.1042\/BST20180320.","journal-title":"Biochem. Soc. Trans."},{"key":"2506_CR101","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1073\/pnas.93.8.3444","volume":"93","author":"Q. Wang","year":"1996","unstructured":"Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.\u00a0H., and Speck, N.\u00a0A. (1996) Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis, Proc. Natl. Acad. Sci. USA, 93, 3444-3449, \nhttps:\/\/doi.org\/10.1073\/pnas.93.8.3444.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR102","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1182\/blood-2004-08-3280","volume":"106","author":"J. D. Growney","year":"2005","unstructured":"Growney, J. D., Shigematsu, H., Li, Z., Lee, B. H., Adelsperger, J., Rowan, R., Curley, D.\u00a0P., Kutok, J.\u00a0L., Akashi, K., Williams, I.\u00a0R., Speck, N.\u00a0A., and Gilliland, D.\u00a0G. (2005) Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype, Blood, 106, 494-504, \nhttps:\/\/doi.org\/10.1182\/blood-2004-08-3280.","journal-title":"Blood"},{"key":"2506_CR103","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.4049\/jimmunol.180.7.4402","volume":"180","author":"M. Ichikawa","year":"2008","unstructured":"Ichikawa, M., Goyama, S., Asai, T., Kawazu, M., Nakagawa, M., Takeshita, M., Chiba, S., Ogawa, S., and Kurokawa, M. (2008) AML1\/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoIesis, J.\u00a0Immunol., 180, 4402-4408, \nhttps:\/\/doi.org\/10.4049\/jimmunol.180.7.4402.","journal-title":"J.\u00a0Immunol."},{"key":"2506_CR104","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ydbio.2012.03.024","volume":"366","author":"Y. Tanaka","year":"2012","unstructured":"Tanaka, Y., Joshi, A., Wilson, N. K., Kinston, S., Nishikawa, S., and G\u00f6ttgens, B. (2012) The\u00a0transcriptional programme controlled by Runx1 during early embryonic blood development, Dev. Biol., 366, 404-419, \nhttps:\/\/doi.org\/10.1016\/j.ydbio.2012.03.024.","journal-title":"Dev. Biol."},{"key":"2506_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1532\/IJH97.05075","volume":"82","author":"T. Yamagata","year":"2005","unstructured":"Yamagata, T., Maki, K., and Mitani, K. (2005) Runx1\/AML1 in normal and abnormal hematopoiesis, Int.\u00a0J. Hematol., 82, 1-8, \nhttps:\/\/doi.org\/10.1532\/IJH97.05075.","journal-title":"Int.\u00a0J. Hematol."},{"key":"2506_CR106","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1182\/blood-2002-09-2708","volume":"101","author":"K. E. Elagib","year":"2003","unstructured":"Elagib, K. E., Racke, F. K., Mogass, M., Khetawat, R., Delehanty, L.\u00a0L., and Goldfarb, A.\u00a0N. (2003) RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation, Blood, 101, 4333-4341, \nhttps:\/\/doi.org\/10.1182\/blood-2002-09-2708.","journal-title":"Blood"},{"key":"2506_CR107","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/emboj\/18.6.1609","volume":"18","author":"W. Y. Kim","year":"1999","unstructured":"Kim, W. Y., Sieweke, M., Ogawa, E., Wee, H. J., Englmeier, U., Graf, T., and Yoshiaki, I. (1999) Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains, EMBO\u00a0J., 18, 169-1620, \nhttps:\/\/doi.org\/10.1093\/emboj\/18.6.1609.","journal-title":"EMBO\u00a0J."},{"key":"2506_CR108","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1128\/MCB.16.3.1231","volume":"16","author":"D. E. Zhang","year":"1996","unstructured":"Zhang, D. E., Hetherington, C. J., Meyers, S., Rhoades, K. L., Larson, C.\u00a0J., Chen, H.\u00a0M., Hiebert, S.\u00a0W., and Tenen, D.\u00a0G. (1996) CCAAT enhancer-binding protein (C\/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter, Mol. Cell. Biol., 16, 1231-1240, \nhttps:\/\/doi.org\/10.1128\/MCB.16.3.1231.","journal-title":"Mol. Cell. Biol."},{"key":"2506_CR109","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1093\/emboj\/17.11.2994","volume":"17","author":"I. Kitabayashi","year":"1998","unstructured":"Kitabayashi, I., Yokoyama, A., Shimizu, K., and Ohki, M. (1998) Interaction and functional cooperation of the leukemia- associated factors AML1 and p300 in myeloid cell differentiation, EMBO\u00a0J., 17, 2994-3004, \nhttps:\/\/doi.org\/10.1093\/emboj\/17.11.2994.","journal-title":"EMBO\u00a0J."},{"key":"2506_CR110","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/emboj\/18.9.2551","volume":"18","author":"R. Yagi","year":"1999","unstructured":"Yagi, R., Chen, L. F., Shigesada, K., Murakami, Y., and Ito, Y. (1999) A\u00a0WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator, EMBO\u00a0J., 18, 2551-2562, \nhttps:\/\/doi.org\/10.1093\/emboj\/18.9.2551.","journal-title":"EMBO\u00a0J."},{"key":"2506_CR111","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.oraloncology.2018.08.020","volume":"86","author":"C. Segrelles","year":"2018","unstructured":"Segrelles, C., Paramio, J. M., and Lorz, C. (2018) The\u00a0transcriptional co-activator YAP: A new player in head and neck cancer, Oral Oncol., 86, 25-32, \nhttps:\/\/doi.org\/10.1016\/j.oraloncology.2018.08.020.","journal-title":"Oral Oncol."},{"key":"2506_CR112","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/cvr\/cvaa034","volume":"116","author":"A. Riddell","year":"2020","unstructured":"Riddell, A., McBride, M., Braun, T., Nicklin, S.\u00a0A., Cameron, E., Loughrey, C.\u00a0M., and Martin, T.\u00a0P. (2020) RUNX1: an emerging therapeutic target for cardiovascular disease, Cardiovasc. Res., 116, 1410-1423, \nhttps:\/\/doi.org\/10.1093\/cvr\/cvaa034.","journal-title":"Cardiovasc. Res."},{"key":"2506_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2022.03.009","volume":"111","author":"S. G. Kellaway","year":"2022","unstructured":"Kellaway, S. G., Coleman, D. J. L., Cockerill, P. N., Raghavan, M., and Bonifer, C. (2022) Molecular basis of hematological disease caused by inherited or acquired RUNX1 mutations, Exp. Hematol., 111, 1-12, \nhttps:\/\/doi.org\/10.1016\/j.exphem.2022.03.009.","journal-title":"Exp. Hematol."},{"key":"2506_CR114","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1074\/jbc.275.1.651","volume":"275","author":"B. Lutterbach","year":"2000","unstructured":"Lutterbach, B., Westendorf, J. J., Linggi, B., Isaac, S., Seto, E., and Hiebert, S. W. (2000) A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia, J.\u00a0Biol. Chem., 275, 651-656, \nhttps:\/\/doi.org\/10.1074\/jbc.275.1.651.","journal-title":"J.\u00a0Biol. Chem."},{"key":"2506_CR115","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1128\/MCB.24.3.1033-1043.2004","volume":"24","author":"Y. Imai","year":"2004","unstructured":"Imai, Y., Kurokawa, M., Yamaguchi, Y., Izutsu, K., Nitta, E., Mitani, K., Satake, M., Noda, T., Ito, Y., and Hirai, H. (2004) The\u00a0corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1, Mol. Cell. Biol., 24, 1033-1043, \nhttps:\/\/doi.org\/10.1128\/MCB.24.3.1033-1043.2004.","journal-title":"Mol. Cell. Biol."},{"key":"2506_CR116","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/icb.2012.6","volume":"90","author":"W. Seo","year":"2012","unstructured":"Seo, W., Tanaka, H., Miyamoto, C., Levanon, D., Groner, Y., and Taniuchi, I. (2012) Roles of VWRPY motif-mediated gene repression by Runx proteins during T-cell development, Immunol. Cell Biol., 90, 827-830, \nhttps:\/\/doi.org\/10.1038\/icb.2012.6.","journal-title":"Immunol. Cell Biol."},{"key":"2506_CR117","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113400","volume":"132 (Supplement","author":"H. Alkadi","year":"2018","unstructured":"Alkadi, H., McKellar, D., Zhen, T., Karpova, T., Garrett, L. J., Gao, Y., Alsadhan, A.\u00a0A., Kwon, E.\u00a0M., Greene, J.\u00a0J., Ball, D.\u00a0A., Cheng, L., Sorrell, A.\u00a0D., and Liu, P.\u00a0P. (2018) The\u00a0VWRPY domain is essential for RUNX1 function in hematopoietic progenitor cell maturation and megakaryocyte differentiation, Blood, 132 (Supplement\u00a01), 1319, \nhttps:\/\/doi.org\/10.1182\/blood-2018-99-113400.","journal-title":"Blood"},{"key":"2506_CR118","doi-asserted-by":"publisher","first-page":"D920","DOI":"10.1093\/nar\/gks1082","volume":"41","author":"J. L. Huret","year":"2013","unstructured":"Huret, J. L., Ahmad, M., Arsaban, M., Bernheim, A., Cigna, J., Desangles, F., Guignard, J.\u00a0C., Jacquemot-Perbal, M.\u00a0C., Labarussias, M., Leberre, V., Malo, A., Morel-Pair, C., Mossafa, H., Potier, J.\u00a0C., Texier, G., Vigui, F., Wan-Senon, S.\u00a0Y.\u00a0C., Zasadzinski, A., and Dessen, P. (2013) Atlas of genetics and cytogenetics in oncology and haematology in\u00a02013, Nucleic Acids Res., 41, D920-D924, \nhttps:\/\/doi.org\/10.1093\/nar\/gks1082.","journal-title":"Nucleic Acids Res."},{"key":"2506_CR119","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1038\/sj.onc.1207727","volume":"23","author":"L. F. Peterson","year":"2004","unstructured":"Peterson, L. F., and Zhang, D. E. (2004) The 8;21 translocation in leukemogenesis, Oncogene, 23, 4255-4262, \nhttps:\/\/doi.org\/10.1038\/sj.onc.1207727.","journal-title":"Oncogene"},{"key":"2506_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(02)01172-1","volume":"303","author":"J. N. Davis","year":"2003","unstructured":"Davis, J. N., McGhee, L., and Meyers, S. (2003) The ETO (MTG8) gene family, Gene, 303, 1-10, \nhttps:\/\/doi.org\/10.1016\/S0378-1119(02)01172-1.","journal-title":"Gene"},{"key":"2506_CR121","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1079-9796(03)00021-4","volume":"30","author":"S. W. Hiebert","year":"2003","unstructured":"Hiebert, S. W., Reed-Inderbitzin, E. F., Amann, J., Irvin, B., Durst, K., and Linggi,\u00a0B. (2003) The t(8;21) fusion protein contacts co-repressors and histone deacetylases to repress the transcription of the p14ARF tumor suppressor, Blood Cells Mol. Dis., 30, 177-183, \nhttps:\/\/doi.org\/10.1016\/S1079-9796(03)00021-4.","journal-title":"Blood Cells Mol. Dis."},{"key":"2506_CR122","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41375-022-01548-7","volume":"36","author":"Y. Hayashi","year":"2022","unstructured":"Hayashi, Y., Harada, Y., and Harada, H. (2022) Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective, Leukemia, 36, 1203-1214, \nhttps:\/\/doi.org\/10.1038\/s41375-022-01548-7.","journal-title":"Leukemia"},{"key":"2506_CR123","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"M. Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M., Fagerberg, L., Hallstr\u00f6m, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, \u00c5., Kampf, C., Sj\u00f6stedt, E., Asplund, A., Olsson, I.\u00a0M., Edlund, K., Lundberg, E., Navani, S., Szigyarto, C.\u00a0A.\u00a0K., Odeberg, J., Djureinovic, D., Takanen, J.\u00a0O., Hober, S., Alm, T., Edqvist, P.\u00a0H., Berling, H., Tegel, H., Mulder, J., Rockberg, J., Nilsson, P., Schwenk, J.\u00a0M., Hamsten, M., Von Feilitzen, K., Forsberg, M., Persson, L., Johansson, F., Zwahlen, M., Von Heijne, G., Nielsen, J., and Pont\u00e9n, F. (2015) Tissue-based map of the human proteome, Science, 347, 1260419, \nhttps:\/\/doi.org\/10.1126\/science.1260419.","journal-title":"Science"},{"key":"2506_CR124","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0145-2126(01)00128-X","volume":"26","author":"C. Perry","year":"2002","unstructured":"Perry, C., Eldor, A., and Soreq, H. (2002) Runx1\/AML1 in leukemia: disrupted association with diverse protein partners, Leuk. Res., 26, 221-228, \nhttps:\/\/doi.org\/10.1016\/S0145-2126(01)00128-X.","journal-title":"Leuk. Res."},{"key":"2506_CR125","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1128\/MCB.18.12.7185","volume":"18","author":"V. Gelmetti","year":"1998","unstructured":"Gelmetti, V., Zhang, J., Fanelli, M., Minucci, S., Pelicci, P.\u00a0G., and Lazar, M.\u00a0A. (1998) Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO, Mol. Cell. Biol., 18, 7185-7191, \nhttps:\/\/doi.org\/10.1128\/MCB.18.12.7185.","journal-title":"Mol. Cell. Biol."},{"key":"2506_CR126","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1128\/MCB.18.12.7176","volume":"18","author":"B. Lutterbach","year":"1998","unstructured":"Lutterbach, B., Westendorf, J. J., Linggi, B., Patten, A., Moniwa, M., Davie, J. R., Huynh, K. D., Bardwell, V.\u00a0J., Lavinsky, R.\u00a0M., Rosenfeld, M.\u00a0G., Glass, C., Seto, E., and Hiebert, S.\u00a0W. (1998) ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors, Mol. Cell. Biol., 18, 7176-7184, \nhttps:\/\/doi.org\/10.1128\/MCB.18.12.7176.","journal-title":"Mol. Cell. Biol."},{"key":"2506_CR127","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1126\/science.1201662","volume":"333","author":"L. Wang","year":"2011","unstructured":"Wang, L., Gural, A., Sun, X. J., Zhao, X., Perna, F., Huang, G., Hatlen, M. A., Vu,\u00a0L., Liu, F., Xu, H., Asai, T., Xu, H., Deblasio, T., Menendez, S., Voza, F., Jiang, Y., Cole, P.\u00a0A., Zhang, J., Melnick, A., Roeder, R.\u00a0G., and Nimer, S.\u00a0D. (2011) The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation, Science, 333, 765-769, \nhttps:\/\/doi.org\/10.1126\/science.1201662.","journal-title":"Science"},{"key":"2506_CR128","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/or.2019.7149","volume":"42","author":"B. A. Ot\u00e1lora-Ot\u00e1lora","year":"2019","unstructured":"Ot\u00e1lora-Ot\u00e1lora, B. A., Henr\u00edquez, B., L\u00f3pez-Kleine, L., and Rojas, A. (2019) RUNX family: oncogenes or tumor suppressors (review), Oncol. Rep., 42, 3-19, \nhttps:\/\/doi.org\/10.3892\/or.2019.7149.","journal-title":"Oncol. Rep."},{"key":"2506_CR129","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1038\/s41388-021-01952-w","volume":"40","author":"K. Rejeski","year":"2021","unstructured":"Rejeski, K., Duque-Afonso, J., and L\u00fcbbert, M. (2021) AML1\/ETO and its function as a regulator of gene transcription via epigenetic mechanisms, Oncogene, 40, 5665-5676, \nhttps:\/\/doi.org\/10.1038\/s41388-021-01952-w.","journal-title":"Oncogene"},{"key":"2506_CR130","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.celrep.2013.08.020","volume":"4","author":"O. Ben-Ami","year":"2013","unstructured":"Ben-Ami, O., Friedman, D., Leshkowitz, D., Goldenberg, D., Orlovsky, K., Pencovich, N., Lotem, J., Tanay, A., and Groner, Y. (2013) Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1, Cell Rep., 4, 1131-1143, \nhttps:\/\/doi.org\/10.1016\/j.celrep.2013.08.020.","journal-title":"Cell Rep."},{"key":"2506_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020350","volume":"20","author":"E. Van der Kouwe","year":"2019","unstructured":"Van der Kouwe, E., and Staber, P. B. (2019) RUNX1-ETO: Attacking the epigenome for genomic instable Leukemia, Int.\u00a0J. Mol. Sci., 20, 350, \nhttps:\/\/doi.org\/10.3390\/ijms20020350.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2506_CR132","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/leu.2012.49","volume":"26","author":"A. Ptasinska","year":"2012","unstructured":"Ptasinska, A., Assi, S. A., Mannari, D., James, S. R., Williamson, D., Dunne, J., Hoogenkamp, M., Wu, M., Care, M., McNeill, H., Cauchy, P., Cullen, M., Tooze, R. M., Tenen, D.\u00a0G., Young, B.\u00a0D., Cockerill, P.\u00a0N., Westhead, D.\u00a0R., Heidenreich, O., and Bonifer, C. (2012) Depletion of RUNX1\/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding, Leukemia, 26, 1829-1841, \nhttps:\/\/doi.org\/10.1038\/leu.2012.49.","journal-title":"Leukemia"},{"key":"2506_CR133","doi-asserted-by":"publisher","first-page":"10398","DOI":"10.1073\/pnas.171321298","volume":"98","author":"Y. Yuan","year":"2001","unstructured":"Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C. J., Burel, S.\u00a0A., Lagasse, E., Weissman, I.\u00a0L., Akashi, K., and Zhang, D.-E. (2001) AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations, Proc. Natl. Acad. Sci. USA, 98, 10398-10403, \nhttps:\/\/doi.org\/10.1073\/pnas.171321298.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR134","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1535-6108(02)00016-8","volume":"1","author":"M. Higuchi","year":"2002","unstructured":"Higuchi, M., O\u2019Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.\u00a0J., and Downing, J.\u00a0R. (2002) Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia, Cancer Cell, 1, 63-74, \nhttps:\/\/doi.org\/10.1016\/S1535-6108(02)00016-8.","journal-title":"Cancer Cell"},{"key":"2506_CR135","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/gcc.20165","volume":"43","author":"T. Kozu","year":"2005","unstructured":"Kozu, T., Fukuyama, T., Yamami, T., Akagi, K., and Kaneko, Y. (2005) MYND-less splice variants of AML1-MTG8 (RUNX1=CBFA2T1) are expressed in leukemia with t(8;21), Genes Chromosomes Cancer, 43, 45-53, \nhttps:\/\/doi.org\/10.1002\/gcc.20165.","journal-title":"Genes Chromosomes Cancer"},{"key":"2506_CR136","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nm1443","volume":"12","author":"M. Yan","year":"2006","unstructured":"Yan, M., Kanbe, E., Peterson, L. F., Boyapati, A., Miao, Y., Wang, Y., Chen, I.\u00a0M., Chen, Z., Rowley, J.\u00a0D., Willman, C.\u00a0L., and Zhang, D.\u00a0E. (2006) A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis, Nat. Med., 12, 945-949, \nhttps:\/\/doi.org\/10.1038\/nm1443.","journal-title":"Nat. Med."},{"key":"2506_CR137","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3324\/haematol.2008.002436","volume":"94","author":"R. K. Slany","year":"2009","unstructured":"Slany, R. K. (2009) The molecular biology of mixed lineage leukemia, Haematologica, 94, 984-993, \nhttps:\/\/doi.org\/10.3324\/haematol.2008.002436.","journal-title":"Haematologica"},{"key":"2506_CR138","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1182\/blood.V66.5.1115.bloodjournal6651115","volume":"66","author":"J. Mirro","year":"1985","unstructured":"Mirro, J., Zipf, T. F., Pui, C. H., Kitchingman, G., Williams, D., Melvin, S., Murphy, S. B., and Stass, S. (1985) Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance, Blood, 66, 1115-1123, \nhttps:\/\/doi.org\/10.1182\/blood.V66.5.1115.bloodjournal6651115.","journal-title":"Blood"},{"key":"2506_CR139","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1182\/blood.V68.2.597.597","volume":"68","author":"J. Mirro","year":"1986","unstructured":"Mirro, J., Kitchingman, G. R., Williams, D. L., Murphy, S.\u00a0B., Zipf, T.\u00a0F., and Stass, S.\u00a0A. (1986) Mixed lineage leukemia: the implications for hematopoietic differentiation, Blood, 68, 597-599, \nhttps:\/\/doi.org\/10.1182\/blood.V68.2.597.597.","journal-title":"Blood"},{"key":"2506_CR140","doi-asserted-by":"publisher","first-page":"10735","DOI":"10.1073\/pnas.88.23.10735","volume":"88","author":"S. Ziemin-Van Der Poel","year":"1991","unstructured":"Ziemin-Van Der Poel, S., Mccabe, N. R., Gill, H. J., Espinosa, R., Patel, Y., Harden, A., Rubinelli, P., Smith, S. D., Lebeau, M. M., Rowley, I. D., and Diaz, M.\u00a0O. (1991) Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias, Proc. Natl. Acad. Sci. USA, 88, 10735-10739, \nhttps:\/\/doi.org\/10.1073\/pnas.88.23.10735.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR141","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/ng1092-113","volume":"2","author":"M. Djabali","year":"1992","unstructured":"Djabali, M., Selleri, L., Parry, P., Bower, M., Young, B.\u00a0D., and Evans, G.\u00a0A. (1992) A\u00a0trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias, Nat. Genet., 2, 113-118, \nhttps:\/\/doi.org\/10.1038\/ng1092-113.","journal-title":"Nat. Genet."},{"key":"2506_CR142","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2141.2010.08459.x","volume":"152","author":"R. Marschalek","year":"2011","unstructured":"Marschalek, R. (2011) Mechanisms of leukemogenesis by MLL fusion proteins, Br.\u00a0J. Haematol., 152, 141-154, \nhttps:\/\/doi.org\/10.1111\/j.1365-2141.2010.08459.x.","journal-title":"Br.\u00a0J. Haematol."},{"key":"2506_CR143","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1182\/blood.V82.12.3705.3705","volume":"82","author":"H. J. G. Super","year":"1993","unstructured":"Super, H. J. G., McCabe, N. R., Thirman, M. J., Larson, R. A., Le Beau, M. M., Pedersen-Bjergaard, J., Philip, P., Diaz, M.\u00a0O., and Rowley, J.\u00a0D. (1993) Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase\u00a0II, Blood, 82, 3705-3711, \nhttps:\/\/doi.org\/10.1182\/blood.V82.12.3705.3705.","journal-title":"Blood"},{"key":"2506_CR144","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","volume":"1400","author":"C. A. Felix","year":"1998","unstructured":"Felix, C. A. (1998) Secondary leukemias induced by topoisomerase-targeted drugs, Biochim. Biophys. Acta, 1400, 233-255, \nhttps:\/\/doi.org\/10.1016\/S0167-4781(98)00139-0.","journal-title":"Biochim. Biophys. Acta"},{"key":"2506_CR145","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrc3929","volume":"15","author":"R. C. Rao","year":"2015","unstructured":"Rao, R. C., and Dou, Y. (2015) Hijacked in cancer: The\u00a0KMT2 (MLL) family of methyltransferases, Nat. Rev. Cancer, 15, 334-346, \nhttps:\/\/doi.org\/10.1038\/nrc3929.","journal-title":"Nat. Rev. Cancer"},{"key":"2506_CR146","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/sj.leu.2402595","volume":"16","author":"A. Borkhardt","year":"2002","unstructured":"Borkhardt, A., Wuchter, C., Viehmann, S., Pils, S., Teigler-Schlegel, A., Stanulla,\u00a0M., Zimmermann, M., Ludwig, W.\u00a0D., Janka-Schaub, G., Schrappe, M., and Harbott, J. (2002) Infant acute lymphoblastic leukemia\u00a0\u2013 combined cytogenetic, immonophenotypical and molecular analysis of 77\u00a0cases, Leukemia, 16, 1685-1690, \nhttps:\/\/doi.org\/10.1038\/sj.leu.2402595.","journal-title":"Leukemia"},{"key":"2506_CR147","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","volume":"370","author":"R. Pieters","year":"2007","unstructured":"Pieters, R., Schrappe, M., De Lorenzo, P., Hann, I., De Rossi, G., Felice, M., Hovi,\u00a0L., LeBlanc, T., Szczepanski, T., Ferster, A., Janka, G., Rubnitz, J., Silverman, L., Stary, J., Campbell, M., Li, C. K., Mann, G., Suppiah, R., Biondi, A., Vora, A., and Valsecchi, M.\u00a0G. (2007) A\u00a0treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial, Lancet, 370, 240-250, \nhttps:\/\/doi.org\/10.1016\/S0140-6736(07)61126-X.","journal-title":"Lancet"},{"key":"2506_CR148","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.2621.2621","volume":"120","author":"U. Creutzig","year":"2012","unstructured":"Creutzig, U., Zimmermann, M., Dworzak, M., Bourquin, J.-P., von Neuhoff, C., Sander, A., Stary, J., and Reinhardt, D. (2012) Additional prognostic impact of specific sites of extramedullary leukemia in pediatric AML with MLL-rearrangements but not in core-binding factor (CBF) AML, Blood, 120, 2621, \nhttps:\/\/doi.org\/10.1182\/blood.V120.21.2621.2621.","journal-title":"Blood"},{"key":"2506_CR149","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3343\/alm.2016.36.2.85","volume":"36","author":"R. Marschalek","year":"2016","unstructured":"Marschalek, R. (2016) Systematic classification of mixed-lineage leukemia fusion partners predicts additional cancer pathways, Ann. Lab. Med., 36, 85-100, \nhttps:\/\/doi.org\/10.3343\/alm.2016.36.2.85.","journal-title":"Ann. Lab. Med."},{"key":"2506_CR150","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4161\/cbt.8.13.8924","volume":"8","author":"H. Liu","year":"2009","unstructured":"Liu, H., Cheng, E. H. Y., and Hsieh, J. J. D. (2009) MLL fusions: pathways to leukemia, Cancer Biol. Ther., 8, 1204-1211, \nhttps:\/\/doi.org\/10.4161\/cbt.8.13.8924.","journal-title":"Cancer Biol. Ther."},{"key":"2506_CR151","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1073\/pnas.0503072102","volume":"102","author":"M. G. Guenther","year":"2005","unstructured":"Guenther, M. G., Jenner, R. G., Chevalier, B., Nakamura, T., Croce, C.\u00a0M., Canaani, E., and Young, R.\u00a0A. (2005) Global and Hox-specific roles for the MLL1 methyltransferase, Proc. Natl. Acad. Sci. USA, 102, 8603-8608, \nhttps:\/\/doi.org\/10.1073\/pnas.0503072102.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR152","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1101\/gad.1111603","volume":"17","author":"P. M. Ayton","year":"2003","unstructured":"Ayton, P. M., and Cleary, M. L. (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9, Genes Dev., 17, 2298-2307, \nhttps:\/\/doi.org\/10.1101\/gad.1111603.","journal-title":"Genes Dev."},{"key":"2506_CR153","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1128\/MCB.00924-09","volume":"29","author":"P. Wang","year":"2009","unstructured":"Wang, P., Lin, C., Smith, E. R., Guo, H., Sanderson, B. W., Wu, M., Gogol, M., Alexander, T., Seidel, C., Wiedemann, L.\u00a0M., Ge, K., Krumlauf, R., and Shilatifard, A. (2009) Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase\u00a0II, Mol. Cell. Biol., 29, 6074-6085, \nhttps:\/\/doi.org\/10.1128\/MCB.00924-09.","journal-title":"Mol. Cell. Biol."},{"key":"2506_CR154","doi-asserted-by":"publisher","first-page":"12000","DOI":"10.1073\/pnas.1301278110","volume":"110","author":"E. L. Artinger","year":"2013","unstructured":"Artinger, E. L., Mishra, B. P., Zaffuto, K. M., Li, B. E., Chung, E. K. Y., Moore, A.\u00a0W., Chen, Y., Cheng, C., and Ernst, P. (2013) An MLL-dependent network sustains hematopoiesis, Proc. Natl. Acad. Sci. USA, 110, 12000-12005, \nhttps:\/\/doi.org\/10.1073\/pnas.1301278110.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR155","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/378505a0","volume":"378","author":"B. D. Yu","year":"1995","unstructured":"Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A. J., and Korsmeyer, S.\u00a0J. (1995) Altered Hox expression and segmental identity in Mll-mutant mice, Nature, 378, 505-508, \nhttps:\/\/doi.org\/10.1038\/378505a0.","journal-title":"Nature"},{"key":"2506_CR156","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1182\/blood.V92.1.108.413k11_108_117","volume":"92","author":"H. Yagi","year":"1998","unstructured":"Yagi, H., Deguchi, K., Aono, A., Tani, Y., Kishimoto, T., and Komori, T. (1998) Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice, Blood, 92, 108-117, \nhttps:\/\/doi.org\/10.1182\/blood.V92.1.108.413k11_108_117.","journal-title":"Blood"},{"key":"2506_CR157","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1534-5807(04)00061-9","volume":"6","author":"P. Ernst","year":"2004","unstructured":"Ernst, P., Fisher, J. K., Avery, W., Wade, S., Foy, D., and Korsmeyer, S.\u00a0J. (2004) Definitive hematopoiesis requires the mixed-lineage leukemia gene, Dev. Cell, 6, 437-443, \nhttps:\/\/doi.org\/10.1016\/S1534-5807(04)00061-9.","journal-title":"Dev. Cell"},{"key":"2506_CR158","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.stem.2007.07.002","volume":"1","author":"K. A. McMahon","year":"2007","unstructured":"McMahon, K. A., Hiew, S. Y. L., Hadjur, S., Veiga-Fernandes, H., Menzel, U., Price, A.\u00a0J., Kioussis, D., Williams, O., and Brady, H.\u00a0J.\u00a0M. (2007) Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal, Cell Stem Cell, 1, 338-345, \nhttps:\/\/doi.org\/10.1016\/j.stem.2007.07.002.","journal-title":"Cell Stem Cell"},{"key":"2506_CR159","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/pro.404","volume":"19","author":"M. M. Garc\u00eda-Alai","year":"2010","unstructured":"Garc\u00eda-Alai, M. M., Allen, M. D., Joerger, A.\u00a0C., and Bycroft, M. (2010) The\u00a0structure of the FYR domain of transforming growth factor beta regulator\u00a01, Protein Sci., 19, 1432-1438, \nhttps:\/\/doi.org\/10.1002\/pro.404.","journal-title":"Protein Sci."},{"key":"2506_CR160","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/nar\/30.4.958","volume":"30","author":"M. Birke","year":"2002","unstructured":"Birke, M., Schreiner, S., Garc\u00eda-Cu\u00e9llar, M.-P., Mahr, K., Titgemeyer, F., and Slany, R.\u00a0K. (2002) The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation, Nucleic Acids Res., 30, 958-965, \nhttps:\/\/doi.org\/10.1093\/nar\/30.4.958.","journal-title":"Nucleic Acids Res."},{"key":"2506_CR161","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/sj.emboj.7601340","volume":"25","author":"M. D. Allen","year":"2006","unstructured":"Allen, M. D., Grummitt, C. G., Hilcenko, C., Min, S.\u00a0Y., Tonkin, L.\u00a0M., Johnson, C.\u00a0M., Freund, S.\u00a0M., Bycroft, M., and Warren, A.\u00a0J. (2006) Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase, EMBO\u00a0J., 25, 4503-4512, \nhttps:\/\/doi.org\/10.1038\/sj.emboj.7601340.","journal-title":"EMBO\u00a0J."},{"key":"2506_CR162","doi-asserted-by":"publisher","first-page":"29901","DOI":"10.1074\/jbc.M113.474858","volume":"288","author":"L. E. Risner","year":"2013","unstructured":"Risner, L. E., Kuntimaddi, A., Lokken, A. A., Achille, N.\u00a0J., Birch, N.\u00a0W., Schoenfelt, K., Bushweller, J.\u00a0H., and Zeleznik-Le, N.\u00a0J. (2013) Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia, J.\u00a0Biol. Chem., 288, 29901-29910, \nhttps:\/\/doi.org\/10.1074\/jbc.M113.474858.","journal-title":"J.\u00a0Biol. Chem."},{"key":"2506_CR163","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ccr.2010.04.012","volume":"17","author":"A. G. Muntean","year":"2010","unstructured":"Muntean, A. G., Tan, J., Sitwala, K., Huang, Y., Bronstein, J., Connelly, J.\u00a0A., Basrur, V., Elenitoba-Johnson, K.\u00a0S.\u00a0J., and Hess, J.\u00a0L. (2010) The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis, Cancer Cell, 17, 609-621, \nhttps:\/\/doi.org\/10.1016\/j.ccr.2010.04.012.","journal-title":"Cancer Cell"},{"key":"2506_CR164","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.cell.2010.05.016","volume":"141","author":"Z. Wang","year":"2010","unstructured":"Wang, Z., Song, J., Milne, T. A., Wang, G. G., Li, H., Allis, C.\u00a0D., and Patel, D.\u00a0J. (2010) Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression, Cell, 141, 1183-1194, \nhttps:\/\/doi.org\/10.1016\/j.cell.2010.05.016.","journal-title":"Cell"},{"key":"2506_CR165","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jmb.2010.05.005","volume":"400","author":"P. Y. Chang","year":"2010","unstructured":"Chang, P. Y., Hom, R. A., Musselman, C. A., Zhu, L., Kuo, A., Gozani, O., Kutateladze, T.\u00a0G., and Cleary, M.\u00a0L. (2010) Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription, J.\u00a0Mol. Biol., 400, 137-144, \nhttps:\/\/doi.org\/10.1016\/j.jmb.2010.05.005.","journal-title":"J.\u00a0Mol. Biol."},{"key":"2506_CR166","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-4-1","volume":"4","author":"T. C. Roloff","year":"2003","unstructured":"Roloff, T. C., Ropers, H. H., and Nuber, U.\u00a0A. (2003) Comparative study of methyl-CpG-binding domain proteins, BMC Genomics, 4,\u00a01, \nhttps:\/\/doi.org\/10.1186\/1471-2164-4-1.","journal-title":"BMC Genomics"},{"key":"2506_CR167","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccr.2008.05.003","volume":"14","author":"A. Yokoyama","year":"2008","unstructured":"Yokoyama, A., and Cleary, M. L. (2008) Menin critically links MLL protein with LEDGF on cancer-associated target genes, Cancer Cell, 14, 36-46, \nhttps:\/\/doi.org\/10.1016\/j.ccr.2008.05.003.","journal-title":"Cancer Cell"},{"key":"2506_CR168","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","volume":"13","author":"C. M. Hughes","year":"2004","unstructured":"Hughes, C. M., Rozenblatt-Rosen, O., Milne, T. A., Copeland, T. D., Levine, S. S., Lee, J. C., Hayes, D. N., Shanmugam, K. S., Bhattacharjee, A., Biondi, C.\u00a0A., Kay, G.\u00a0F., Hayward, N. K., Hess, J. L., and Meyerson, M. (2004) Menin associates with a trithorax family histone methyltransferase complex and with the Hoxc8 locus, Mol. Cell, 13, 587-597, \nhttps:\/\/doi.org\/10.1016\/S1097-2765(04)00081-4.","journal-title":"Mol. Cell"},{"key":"2506_CR169","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1038\/onc.2016.30","volume":"35","author":"R. K. Slany","year":"2016","unstructured":"Slany, R. K. (2016) The\u00a0molecular mechanics of mixed lineage leukemia, Oncogene, 35, 5215-5223, \nhttps:\/\/doi.org\/10.1038\/onc.2016.30.","journal-title":"Oncogene"},{"key":"2506_CR170","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.4161\/epi.6.9.16069","volume":"6","author":"P. A. Del Rizzo","year":"2011","unstructured":"Del Rizzo, P. A., and Trievel, R. C. (2011) Substrate and product specificities of SET domain methyltransferases, Epigenetics, 6, 1059-1067, \nhttps:\/\/doi.org\/10.4161\/epi.6.9.16069.","journal-title":"Epigenetics"},{"key":"2506_CR171","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nsmb1128","volume":"13","author":"Y. Dou","year":"2006","unstructured":"Dou, Y., Milne, T. A., Ruthenburg, A. J., Lee, S., Lee, J. W., Verdine, G. L., Allis, C. D., and Roeder, R. G. (2006) Regulation of MLL1 H3K4 methyltransferase activity by its core components, Nat. Struct. Mol. Biol., 13, 713-719, \nhttps:\/\/doi.org\/10.1038\/nsmb1128.","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2506_CR172","doi-asserted-by":"publisher","first-page":"24242","DOI":"10.1074\/jbc.M109.014498","volume":"284","author":"A. Patel","year":"2009","unstructured":"Patel, A., Dharmarajan, V., Vought, V. E., and Cosgrove, M.\u00a0S. (2009) On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex, J.\u00a0Biol. Chem., 284, 24242-24256, \nhttps:\/\/doi.org\/10.1074\/jbc.M109.014498.","journal-title":"J.\u00a0Biol. Chem."},{"key":"2506_CR173","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature16952","volume":"530","author":"Y. Li","year":"2016","unstructured":"Li, Y., Han, J., Zhang, Y., Cao, F., Liu, Z., Li, S., Wu, J., Hu, C., Wang, Y., Shuai,\u00a0J., Chen, J., Cao, L., Li, D., Shi, P., Tian, C., Zhang, J., Dou, Y., Li, G., Chen, Y., and Lei, M. (2016) Structural basis for activity regulation of MLL family methyltransferases, Nature, 530, 447-452, \nhttps:\/\/doi.org\/10.1038\/nature16952.","journal-title":"Nature"},{"key":"2506_CR174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0237956","volume":"16","author":"N. R. Lloyd","year":"2021","unstructured":"Lloyd, N. R., and Wuttke, D. S. (2021) Cyp33 binds AU-rich RNA motifs via an extended interface that competitively disrupts the gene repressive Cyp33-MLL1 interaction in vitro, PLoS One, 16, 1-18, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0237956.","journal-title":"PLoS One"},{"key":"2506_CR175","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1128\/MCB.21.10.3589-3597.2001","volume":"21","author":"K. Fair","year":"2001","unstructured":"Fair, K., Anderson, M., Bulanova, E., Mi, H., Tropschug, M., and Diaz, M.\u00a0O. (2001) Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells, Mol. Cell. Biol., 21, 3589-3597, \nhttps:\/\/doi.org\/10.1128\/MCB.21.10.3589-3597.2001.","journal-title":"Mol. Cell. Biol."},{"key":"2506_CR176","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1073\/pnas.1436338100","volume":"100","author":"Z. B. Xia","year":"2003","unstructured":"Xia, Z. B., Anderson, M., Diaz, M. O., and Zeleznik-Le, N.\u00a0J. (2003) MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein, Proc. Natl. Acad. Sci. USA, 100, 8342-8347, \nhttps:\/\/doi.org\/10.1073\/pnas.1436338100.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2506_CR177","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.cell.2010.06.013","volume":"141","author":"E. J. Grow","year":"2010","unstructured":"Grow, E. J., and Wysocka, J. (2010) Flipping MLL1\u2019s switch one proline at a time, Cell, 141, 1108-1110, \nhttps:\/\/doi.org\/10.1016\/j.cell.2010.06.013.","journal-title":"Cell"},{"key":"2506_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2020.194561","volume":"1863","author":"L. Sha","year":"2020","unstructured":"Sha, L., Ayoub, A., Cho, U. S., and Dou, Y. (2020) Insights on the regulation of the MLL\/SET1 family histone methyltransferases, Biochim. Biophys. Acta Gene Regul. Mech., 1863, 194561, \nhttps:\/\/doi.org\/10.1016\/j.bbagrm.2020.194561.","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"2506_CR179","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1158\/0008-5472.CAN-07-6514","volume":"68","author":"J. Chen","year":"2008","unstructured":"Chen, J., Santillan, D. A., Koonce, M., Wei, W., Luo, R., Thirman, M.\u00a0J., Zeleznik-Le, N.\u00a0J., and Diaz, M.\u00a0O. (2008) Loss of MLL PHD finger\u00a03 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization, Cancer Res., 68, 6199-6207, \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6514.","journal-title":"Cancer Res."},{"key":"2506_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2019.00081","volume":"7","author":"A. K. N. Chan","year":"2019","unstructured":"Chan, A. K. N., and Chen, C. W. (2019) Rewiring the epigenetic networks in MLL-rearranged leukemias: Epigenetic dysregulation and pharmacological interventions, Front. Cell Dev. Biol., 7, 1-15, \nhttps:\/\/doi.org\/10.3389\/fcell.2019.00081.","journal-title":"Front. Cell Dev. Biol."},{"key":"2506_CR181","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41401-022-00999-z","volume":"44","author":"Q. L. Han","year":"2022","unstructured":"Han, Q. L., Zhang, X. L., Ren, P.\u00a0X., Mei, L.\u00a0H., Lin, W.\u00a0H., Wang, L., Cao, Y., Li, K., and Bai, F. (2022) Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma, Acta Pharmacol. Sin., 44, 877-887, \nhttps:\/\/doi.org\/10.1038\/s41401-022-00999-z.","journal-title":"Acta Pharmacol. Sin."},{"key":"2506_CR182","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.critrevonc.2014.03.004","volume":"91","author":"R. L. Wright","year":"2014","unstructured":"Wright, R. L., and Vaughan, A. T. M. (2014) A\u00a0systematic description of MLL fusion gene formation, Crit. Rev. Oncol. Hematol., 91, 283-291, \nhttps:\/\/doi.org\/10.1016\/j.critrevonc.2014.03.004.","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2506_CR183","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1182\/blood-2003-01-0338","volume":"102","author":"M. E. Ross","year":"2003","unstructured":"Ross, M. E., Zhou, X., Song, G., Shurtleff, S. A., Girtman, K., Williams, W. K., Liu, H.\u00a0C., Mahfouz, R., Raimondi, S.\u00a0C., Lenny, N., Patel, A., and Downing, J.\u00a0R. (2003) Classification of pediatric acute lymphoblastic leukemia by gene expression profiling, Blood, 102, 2951-2959, \nhttps:\/\/doi.org\/10.1182\/blood-2003-01-0338.","journal-title":"Blood"},{"key":"2506_CR184","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1182\/blood-2002-10-3221","volume":"102","author":"A. A. Ferrando","year":"2003","unstructured":"Ferrando, A. A., Armstrong, S. A., Neuberg, D. S., Sallan, S.\u00a0E., Silverman, L.\u00a0B., Korsmeyer, S.\u00a0J., and Look, A.\u00a0T. (2003) Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation, Blood, 102, 262-268, \nhttps:\/\/doi.org\/10.1182\/blood-2002-10-3221.","journal-title":"Blood"},{"key":"2506_CR185","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","volume":"37","author":"C. Lin","year":"2010","unstructured":"Lin, C., Smith, E. R., Takahashi, H., Lai, K. C., Martin-Brown, S., Florens, L., Washburn, M.\u00a0P., Conaway, J.\u00a0W., Conaway, R.\u00a0C., and Shilatifard, A. (2010) AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia, Mol. Cell, 37, 429-437, \nhttps:\/\/doi.org\/10.1016\/j.molcel.2010.01.026.","journal-title":"Mol. Cell"},{"key":"2506_CR186","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","volume":"17","author":"A. Yokoyama","year":"2010","unstructured":"Yokoyama, A., Lin, M., Naresh, A., Kitabayashi, I., and Cleary, M.\u00a0L. (2010) A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription, Cancer Cell, 17, 198-212, \nhttps:\/\/doi.org\/10.1016\/j.ccr.2009.12.040.","journal-title":"Cancer Cell"},{"key":"2506_CR187","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/hmg\/ddl444","volume":"16","author":"E. Bitoun","year":"2007","unstructured":"Bitoun, E., Oliver, P. L., and Davies, K. E. (2007) The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase\u00a0II transcriptional elongation and mediates coordinated chromatin remodeling, Hum. Mol. Genet., 16, 92-106, \nhttps:\/\/doi.org\/10.1093\/hmg\/ddl444.","journal-title":"Hum. Mol. Genet."},{"key":"2506_CR188","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000249","volume":"7","author":"D. Mueller","year":"2009","unstructured":"Mueller, D., Garc\u00eda-Cu\u00e9llar, M. P., Bach, C., Buhl, S., Maethner, E., and Slany,\u00a0R.\u00a0K. (2009) Misguided transcriptional elongation causes mixed lineage leukemia, PLoS Biol., 7, e1000249, \nhttps:\/\/doi.org\/10.1371\/journal.pbio.1000249.","journal-title":"PLoS Biol."},{"key":"2506_CR189","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1101\/gad.2057811","volume":"25","author":"A. T. Nguyen","year":"2011","unstructured":"Nguyen, A. T., and Zhang, Y. (2011) The diverse functions of Dot1 and H3K79 methylation, Genes Dev., 25, 1345-1358, \nhttps:\/\/doi.org\/10.1101\/gad.2057811.","journal-title":"Genes Dev."},{"key":"2506_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10844-3","volume":"10","author":"L. Godfrey","year":"2019","unstructured":"Godfrey, L., Crump, N. T., Thorne, R., Lau, I. J., Repapi, E., Dimou, D., Smith, A.\u00a0L., Harman, J.\u00a0R., Telenius, J.\u00a0M., Oudelaar, A.\u00a0M., Downes, D.\u00a0J., Vyas, P., Hughes, J.\u00a0R., and Milne, T.\u00a0A. (2019) DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation, Nat. Commun., 10, 2803, \nhttps:\/\/doi.org\/10.1038\/s41467-019-10844-3.","journal-title":"Nat. Commun."},{"key":"2506_CR191","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1038\/onc.2016.488","volume":"36","author":"K. H. M. Prange","year":"2017","unstructured":"Prange, K. H. M., Mandoli, A., Kuznetsova, T., Wang, S. Y., Sotoca, A. M., Marneth, A.\u00a0E., Van Der Reijden, B.\u00a0A., Stunnenberg, H.\u00a0G., and Martens, J.\u00a0H.\u00a0A. (2017) MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia, Oncogene, 36, 3346-3356, \nhttps:\/\/doi.org\/10.1038\/onc.2016.488.","journal-title":"Oncogene"},{"key":"2506_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2020.194547","volume":"1863","author":"R. Marschalek","year":"2020","unstructured":"Marschalek, R. (2020) The\u00a0reciprocal world of MLL fusions: A personal view, Biochim. Biophys. Acta Gene Regul. Mech., 1863, 194547, \nhttps:\/\/doi.org\/10.1016\/j.bbagrm.2020.194547.","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"2506_CR193","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1038\/sj.onc.1210125","volume":"26","author":"A. Gaussmann","year":"2007","unstructured":"Gaussmann, A., Wenger, T., Eberle, I., Bursen, A., Bracharz, S., Herr, I., Dingermann, T., and Marschalek, R. (2007) Combined effects of the two reciprocal t(4;11) fusion proteins MLL\u00b7AF4 and AF4\u00b7MLL confer resistance to apoptosis, cell cycling capacity and growth transformation, Oncogene, 26, 3352-3363, \nhttps:\/\/doi.org\/10.1038\/sj.onc.1210125.","journal-title":"Oncogene"},{"key":"2506_CR194","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1093\/nar\/gkq307","volume":"38","author":"I. Eberle","year":"2010","unstructured":"Eberle, I., Pless, B., Braun, M., Dingermann, T., and Marschalek,\u00a0R. (2010) Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells, Nucleic Acids Res., 38, 5384-5395, \nhttps:\/\/doi.org\/10.1093\/nar\/gkq307.","journal-title":"Nucleic Acids Res."},{"key":"2506_CR195","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1038\/s41388-021-02001-2","volume":"40","author":"A. Wilhelm","year":"2021","unstructured":"Wilhelm, A., and Marschalek, R. (2021) The\u00a0role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11), Oncogene, 40, 6093-6102, \nhttps:\/\/doi.org\/10.1038\/s41388-021-02001-2.","journal-title":"Oncogene"},{"key":"2506_CR196","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/nm.4410","volume":"23","author":"A. A. Ferrando","year":"2017","unstructured":"Ferrando, A. A., and L\u00f3pez-Ot\u00edn, C. (2017) Clonal evolution in leukemia, Nat. Med., 23, 1135-1145, \nhttps:\/\/doi.org\/10.1038\/nm.4410.","journal-title":"Nat. Med."},{"key":"2506_CR197","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M. Greaves","year":"2012","unstructured":"Greaves, M., and Maley, C. C. (2012) Clonal evolution in cancer, Nature, 481, 306-313, \nhttps:\/\/doi.org\/10.1038\/nature10762.","journal-title":"Nature"},{"key":"2506_CR198","first-page":"25","volume":"5","author":"S. Anoun","year":"2013","unstructured":"Anoun, S., Lamchahab, M., Qachouh, M., Benchekroun, S., and Quessar, A. (2013) A\u00a0case of acute myeloid leukemia caused by low dose methotrexate used to treat a rheumatoid arthritis patient, Iran.\u00a0J. Blood Cancer, 5, 25-28.","journal-title":"Iran.\u00a0J. Blood Cancer"},{"key":"2506_CR199","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature13902","volume":"516","author":"D. Maddalo","year":"2014","unstructured":"Maddalo, D., Manchado, E., Concepcion, C. P., Bonetti, C., Vidigal, J.\u00a0A., Han, Y.\u00a0C., Ogrodowski, P., Crippa, A., Rekhtman, N., De\u00a0Stanchina, E., Lowe, S.\u00a0W., and Ventura, A. (2014) In\u00a0vivo engineering of oncogenic chromosomal rearrangements with the CRISPR\/Cas9 system, Nature, 516, 423-428, \nhttps:\/\/doi.org\/10.1038\/nature13902.","journal-title":"Nature"},{"key":"2506_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms4964","volume":"5","author":"R. Torres","year":"2014","unstructured":"Torres, R., Martin, M. C., Garcia, A., Cigudosa, J.\u00a0C., Ramirez, J.\u00a0C., and Rodriguez-Perales, S. (2014) Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system, Nat. Commun., 5, 1-8, \nhttps:\/\/doi.org\/10.1038\/ncomms4964.","journal-title":"Nat. Commun."},{"key":"2506_CR201","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28633","volume":"95","author":"F. B. Sall","year":"2023","unstructured":"Sall, F. B., Shmakova, A., Karpukhina, A., Tsfasman, T., Lomov, N., Canoy, R. J., Boutboul, D., Oksenhendler, E., Toure, A. O., Lipinski, M., Wiels, J., Germini, D., and Vassetzky, Y. (2023) Epstein\u2013Barr virus reactivation induces MYC-IGH spatial proximity and t(8;14) in B cells, J.\u00a0Med. Virol., 95, e28633, \nhttps:\/\/doi.org\/10.1002\/jmv.28633.","journal-title":"J.\u00a0Med. Virol."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297923070040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297923070040","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297923070040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:22:53Z","timestamp":1773620573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297923070040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":201,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2506"],"URL":"https:\/\/doi.org\/10.1134\/s0006297923070040","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"6 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest. This article does not contain description of studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}